Rami Katkhuda
Stock Analyst at LifeSci Capital
(4.90)
# 257
Out of 4,478 analysts
308
Total ratings
58.1%
Success rate
32.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rami Katkhuda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Rated: Buy | $35 | $18.99 | +84.31% | 47 | Jun 29, 2026 | |
| ELDN Eledon Pharmaceuticals | Maintained: Buy | $8 | $3.97 | +101.51% | 41 | Jun 27, 2026 | |
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | $33 | $18.88 | +74.79% | 41 | Jun 22, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | $135 | $122.07 | +10.59% | 1 | Jun 16, 2026 | |
| IRON Disc Medicine | Maintained: Buy | $100 | $77.01 | +29.85% | 38 | Jun 15, 2026 | |
| DNTH Dianthus Therapeutics | Rated: Buy | $125 | $93.34 | +33.92% | 23 | Jun 12, 2026 | |
| JBIO Jade Biosciences | Maintained: Buy | $42 | $21.30 | +97.18% | 4 | Jun 6, 2026 | |
| VERA Vera Therapeutics | Maintained: Buy | $90 | $40.13 | +124.27% | 36 | Jun 2, 2026 | |
| MLYS Mineralys Therapeutics | Rated: Buy | $54 | $29.12 | +85.44% | 24 | Jun 1, 2026 | |
| AMLX Amylyx Pharmaceuticals | Maintained: Buy | $24 | $17.97 | +33.56% | 13 | May 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 | $32.35 | +76.20% | 6 | May 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $3.90 | +258.97% | 12 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.6675 | - | 22 | Aug 14, 2025 |
Viridian Therapeutics
Jun 29, 2026
Rated: Buy
Price Target: $35
Current: $18.99
Upside: +84.31%
Eledon Pharmaceuticals
Jun 27, 2026
Maintained: Buy
Price Target: $8
Current: $3.97
Upside: +101.51%
MoonLake Immunotherapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $33
Current: $18.88
Upside: +74.79%
Veradermics
Jun 16, 2026
Initiated Coverage: Buy
Price Target: $135
Current: $122.07
Upside: +10.59%
Disc Medicine
Jun 15, 2026
Maintained: Buy
Price Target: $100
Current: $77.01
Upside: +29.85%
Dianthus Therapeutics
Jun 12, 2026
Rated: Buy
Price Target: $125
Current: $93.34
Upside: +33.92%
Jade Biosciences
Jun 6, 2026
Maintained: Buy
Price Target: $42
Current: $21.30
Upside: +97.18%
Vera Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $90
Current: $40.13
Upside: +124.27%
Mineralys Therapeutics
Jun 1, 2026
Rated: Buy
Price Target: $54
Current: $29.12
Upside: +85.44%
Amylyx Pharmaceuticals
May 16, 2026
Maintained: Buy
Price Target: $24
Current: $17.97
Upside: +33.56%
May 16, 2026
Maintained: Buy
Price Target: $57
Current: $32.35
Upside: +76.20%
Mar 31, 2026
Maintained: Buy
Price Target: $14
Current: $3.90
Upside: +258.97%
Aug 14, 2025
Maintained: Hold
Price Target: n/a
Current: $0.6675
Upside: -